New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with β-lactam antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue SUPPL. 2, 2002, Pages 93-100

  Aguilar, L ^a   Gimenez M J ^a   Garcia Rey C ^a   Martin J E ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG USE; ERADICATION THERAPY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PRESCRIPTION; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PRESCRIPTIONS, DRUG; STREPTOCOCCUS PNEUMONIAE;

EID: 0036983313     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf501     Document Type: Review

References (75)

1. Moellering, R. C., Jr (1998). Problems with antimicrobial resistance in gram-positive cocci. Clinical Infectious Diseases 26, 1177-8.
2. Dagan, R., Klugman, K. P., Craig, W. A. & Baquero, F. (2001). Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. Journal of Antimicrobial Chemotherapy 47, 129-40.
3. Felmingham, D. & Grüneberg, R. N. (2000). The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 45, 191-203.
4. Ball, P., Baquero, F., Cars, O., File, T., Garau, J., Klugman, K. P. et al. (2002). Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. Journal of Antimicrobial Chemotherapy 49, 31-40.
5. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliot, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, 1831-5.
6. Schappert, S. M. (1992). Office Visits for Otitis Media: United States, 1975-90. Advance Data from Vital and Health Statistics. Volume 8, pp. 1-19. National Center for Health Statistics, Hyattsville, MD, USA.
7. MacFarlane, J. T., Colville, A., Guion, A., MacFarlane, R. M. & Rose, D. M. (1993). Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 341, 511-4.
8. Sopena, N., Sabriàa, M. L., Pedro-Botet, J. M., Manterola, J. M., Matas, L., Dominguez, J. et al. (1999). Prospective study of community-acquired pneumonia of bacterial etiology in adults. European Journal of Clinical Microbiology and Infectious Diseases 18, 852-8.
9. Lim, W. S., MacFarlane, J. T., Boswell, T. C., Harrison, T. G., Rose, D., Leinonen, M. et al. (2001). Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56, 296-301.
10. Huovinen, P. & Cars, O. (1998). Control of antimicrobial resistance: time for action. British Medical Journal 317, 613-4.
11. Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefánsdóttir, G., Mölstad, S. & Gudmundsson, S. (1996). Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. British Medical Journal 313, 387-91.
12. Pérez-Trallero, E., Fernández-Mazarrasa, C., García-Rey, C., Bouza, E., Aguilar, L., García-de-Lomas, J. et al. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrobial Agents and Chemotherapy 45, 3334-40.
13. García-Rey, C., Aguilar, L., Baquero, F., Casal, J. & Dal-Ré, R. (2002). Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. Journal of Clinical Microbiology 40, 159-64.
14. Doern, G. V. (2001). Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clinical Infectious Diseases 33, Suppl. 3, S187-92.
15. Dancer, S. J. (2001). The problem with cephalosporins. Journal of Antimicrobial Chemotherapy 48, 463-78.
16. Richter, S. S., Heilmann, K. P., Coffman, S. L., Huynh, H. K., Brueggemann, A. B., Pfaller, M. A. et al. (2002). The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clinical Infectious Diseases 34, 330-9.
17. Ball, P. (1999). Therapy for pneumococcal infection at the millennium: doubts and certainties. American Journal of Medicine 107, Suppl. 1A, 77S-85S.
18. Soriano, F. (2001). Selección de bacterias resistentes a los antibióticos: factores microbiológicos y farmacológicos. Medicina Clínica 117, 632-6.
19. Li, R. C., Nix, D. E. & Schentag J. J. (1994). Pharmacodynamic modeling of bacterial kinetics: β-lactam antibiotics against Escherichia coli. Journal of Pharmaceutical Sciences 83, 970-5.
20. Aguilar, L., García-Rey, C. & Giménez, M. J. (2001). Presión antibiótica, desarrollo de resistencias en Streptococcus pneumoniae y fracaso clínico: un círculo no tan vicioso para algunos antibióticos. Spanish Journal of Chemotherapy 14, 17-21.
21. Kelly, M. A., Weber, D. J., Gilligan, P. & Cohen, M. S. (2000). Breakthrough pneumococcal bacteraemia in patients being treated with azithromycin and clarithromycin. Clinical Infectious Diseases 31, 1008-11.
22. Garau, J., Lonks, J. R., Gómez, L., Xercavins, M. & Medeiros, A. (2000). Failure of macrolide therapy in patients with bacteremia due to macrolide resistant Streptococcus pneumoniae. In Program and Abstracts of the Fifth International Conference on Macrolides, Azalides, Streptogramins, Ketolides and Oxazolidinones, Seville, 2000. Abstract 7.09.
23. Pérez-Trallero, E., García-Arenzana, J. M., Jiménez, J. A. & Peris, A. (1990). Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. European Journal of Clinical Microbiology and Infectious Diseases 9, 905-6.
24. Soriano, F. (1999). Lectura farmacodinámica de la sensibilidad antibiótica a Streptococcus pneumoniae. Medicina Clínica 113, 103-8.
25. Pallarés, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F. & Viladrich, P. F. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. New England Journal of Medicine 333, 474-80.
26. Feikin, D. R., Schuchat, A., Kolczak, M., Barrett, N. L., Harrison, L. H., Lefkowitz, L. et al. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. American Journal of Public Health 90, 223-9.
27. García-Rey, C., Aguilar, L. & Baquero, F. on behalf of the Spanish Surveillance Group for Respiratory Pathogens. (2000). Influence of different factors on the ciprofloxacin resistance prevalence of Streptococcus pneumoniae in Spain. Antimicrobial Agents and Chemotherapy 44, 3481-2.
28. Granizo, J. J., Aguilar, L., Casal, J., García-Rey, C., Dal-Ré, R. & Baquero, F. (2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain. Journal of Antimicrobial Chemotherapy 46, 767-73.
29. Gómez-Lus, R., Granizo, J. J., Aguilar, L., Bouza, E., García de Lomas, J. & the Spanish Surveillance Group for Respiratory Pathogens. (1999). Is there any ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? Journal of Clinical Microbiology 37, 3384-6.
30. Drusano, G. L. & Craig, W. A. (1997). Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Journal of Chemotherapy 9, Suppl. 3, 38-44.
31. National Committee for Clinical Laboratory Standards. (2001). Performance Standards for Antimicrobial Susceptibility Testing - Eleventh Informational Supplement. NCCLS Document M100-S11. NCCLS, Wayne, PA, USA.
32. Austin, D. J., Kristinsson, K. G. & Anderson, R. M. (1999). The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences, USA 96, 1152-6.
33. Musher, D. M., Bartlett, J. G. & Doern, G. V. (2001). A fresh look at the definition of susceptibility of Streptococcus pneumoniae to β-lactam antibiotics. Archives of Internal Medicine 161, 2538-44.
34. McDougal, L. K., Rasheed, J. K., Biddle, J. W. & Tenover, F. C. (1995). Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrobial Agents and Chemotherapy 39, 2282-8.
35. Craig, W. A. & Andes, D. (1996). Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatric Infectious Disease Journal 15, 255-9.
36. Soriano, F., Parra, A., Cenjor, C., Nieto, E., García-Calvo, G., Giménez, M. J. et al. (2000). Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. Journal of Infectious Diseases 181, 646-52.
37. Parra, A., Ponte, C., Cenjor, C., García-Calvo, G., Giménez, M. J., Aguilar, L. et al. (2002). Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model. Antimicrobial Agents and Chemotherapy 46, 859-62.
38. Baquero, F. (1999). Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? Journal of Chemotherapy 11, Suppl. 1, 35-43.
39. Baquero, F. & Negri, M. C. (1997). Strategies to minimize the development of antibiotic resistance. Journal of Chemotherapy 9, Suppl. 3, 29-37.
40. Baquero, F. (1996). Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 117-32.
41. Thorburn, C. E., Knott, S. J. & Edwards, D. I. (1998). In vitro activities of oral β-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance. Antimicrobial Agents and Chemotherapy 42, 1973-9.
42. Negri, M. C., Morosini, M. I., Loza, E. & Baquero, F. (1994). In vitro selective antibiotic concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrobial Agents and Chemotherapy 38, 122-5.
43. Drusano, G. L. & Goldstein, F. W. (1996). Relevance of the Alexander Project: pharmacodynamic considerations. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 141-54.
44. Gray, B. M., Converse G. M., III & Dillon, H. C., Jr (1980). Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. Journal of Infectious Diseases 142, 923-33.
45. Ghaffar, F., Friedland, I. R. & McCracken, G. H., Jr (1999). Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatric Infectious Disease Journal 18, 638-46.
46. Marco, F., Bouza, E., García-de-Lomas, J., Aguilar, L. & the Spanish Surveillance Group for Respiratory Pathogens. (2000). Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. Journal of Antimicrobial Chemotherapy 46, 557-64.
47. Ghaffar, F., McCracken, G. H., Jr & Friedland, I. (1998). Effect of amoxicillin/clavulanate vs azithromycin on nasopharyngeal carriage and resistance of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. In Program and Abstracts of the Thirty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, USA, 1998. Abstract C-30, p. 77. American Society for Microbiology, Washington, DC, USA.
48. Cohen, R., Bingen, E., Varon, E., de La Rocque, F., Brahimi, N., Levy, C. et al. (1997). Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatric Infectious Disease Journal 16, 555-60.
49. Schricker, M. E., Schreiber J. R., Chiarucci, K., Kerman, J., Noe, A., Jacobs, M. R. et al. (1993). Absence of antibiotic-resistant Streptococcus pneumoniae pharyngeal colonization in Cleveland children with sickle cell disease. Pediatric Infectious Disease Journal 12, 775-7.
50. Fenoll, A., Casal, J., Giménez, M. J., Jado, I. & Aguilar, L. (2000). Short-term bactericidal activity of amoxicillin and cefolaxime against penicillin susceptible and resistant pneumococcal strains: an in vitro pharmacodynamic simulation. Journal of Chemotherapy 12, 124-8.
51. Prieto, J., Giménez, M. J., Balcabao, I. P., Gómez-Lus, M. L. & Aguilar, L. (1999). Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation. Journal of Chemotherapy 11, 345-8.
52. Balcabao, I. P., Aguilar, L., Martín, M., García, Y., Dal-Ré, R. & Prieto, J. (1996). Activities against Streptococcus pneumoniae of amoxicillin and cefolaxime at physiological concentrations: in vitro pharmacodynamic simulation. Antimicrobial Agents and Chemotherapy 40, 2904-6.
53. Aguilar, L., Rosendo, J., Balcabao, I. P., Martín, M., Giménez, M. J., Frías, J. et al. (1997). Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a Phase I study. Antimicrobial Agents and Chemotherapy 41, 1389-91.
54. Cenjor, C., Ponte, C., Parra, A., Nieto, E., García-Calvo, G., Giménez, M. J. et al. (1998). In vivo efficacy of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. Antimicrobial Agents and Chemotherapy 42, 1361-4.
55. Soriano, F., Ponte, C., Nieto, E. & Parra, A. (1996). Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxicillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia. Journal of Antimicrobial Chemotherapy 38, 227-36.
56. Pérez-Trallero, E., Alkorta, M., Giménez, M. J., Vicente, D. & Aguilar, L. (2001). Prediction of in-vivo efficacy by in-vitro early bactericidal activity, with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. Journal of Chemotherapy 13, 118-25.
57. Yuste, J., Jado, I., Fenoll, A., Aguilar, L., Giménez, M. J. & Casal, J. (2002). β-Lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model. Journal of Antimicrobial Chemotherapy 49, 331-5.
58. Dagan, R., Abramson, O., Leibovitz, E., Lang, R., Goshen, S., Greenberg, D. et al. (1996). Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatric Infectious Disease Journal 15, 980-5.
59. Dagan, R., Piglansky, L., Fliss, D. M., Leiberman, A. & Leibovitz, E. (1997). Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor and amoxicillin, In Program and Abstracts of the Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada. Abstract K-103, p. 346. American Society for Microbiology, Washington, DC, USA.
60. Goldsmith, C. E., Moore, J. E. & Murphy, P. G. (1996). Prevalence of antibiotic resistance in pneumococci is higher in Northern Ireland. British Medical Journal 313, 820.
61. Kaye, C. M., Allen, A., Perry, S., McDonagh, M., Davy, M., Storm, K. et al. (2001). The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate. Clinical Therapeutics 23, 578-84.
62. Berry, V., Singley, C., Satterfield, J. & Woodnutt, G. (2001). Efficacy of a pharmacokinetically enhanced formulation of amoxicillin/clavulanate against experimental respiratory tract infection (RTI) in rats caused by Streptococcus pneumoniae (Sp.). In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract B-988, p. 53. American Society for Microbiology, Washington, DC, USA.
63. File, T., Jacobs, M., Poole, M., Richard, M. & Wynne, B. (2001). Clinical efficacy of pharmacokinetically enhanced amoxicillin/clavulanate (AMX/CA) vs comparators against Streptococcus pneumoniae (Sp) in respiratory tract infections (RTIs). In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract L-866, p. 451. American Society for Microbiology, Washington, DC, USA.
64. Blumer, J. L. (1998). Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media. Pediatric Infectious Disease Journal 17, 1070-5.
65. Dowell, S. F., Butler, J. C., Giebink, G. S., Jacobs, M. R., Jernigan, D., Musher, D. M. et al. (1999). Acute otitis media: management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatric Infectious Disease Journal 18, 1-9.
66. Leibovitz, E., Piglansky, L., Raiz, S., Yagupsky, P, Press, J., Fliss, D. M. et al. (1998). The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone (IMN-CRO) in the treatment of non-responsive acute otitis media (NR-AOM). In Program and Abstracts of the Thirty-eighth Interscience, Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, USA, 1998. Abstract MN-39, p. 599. American Society for Microbiology, Washington, DC, USA.
67. Severin, A., Severina, E. & Tomasz, A. (1997). Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid. Antimicrobial Agents and Chemotherapy 41, 504-10.
68. Prieto, J., Frías, J., Alou, L. & Carcas, A. (1998). Estudio de la actividad bactericida de la combinación amoxicilina/αcido clavulánico y sus posibles efectos ante la resistencia a betalactámicos de Streptococcus pneumoniae. Medicina Clínica 110, Suppl. 1, 12-5.
69. Gómez-Lus, M. L., Aguilar, L., Martín, M., Giménez, M. J., Martínez, P. & Prieto, P. (1997). Intracellular and extracellular killing of a penicillin-resistant, serotype-9 strain of Streptococcus pneumoniae by polymorphonuclear leucocytes in the presence of subinhibitory concentrations of clavulanic acid. Journal of Antimicrobial Chemotherapy 40, 142-4.
70. Martín, M., Gómez-Lus, M. L., Aguilar, L., Martínez, P., Giménez, M. J. & Prieto, J. (1997). Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae. European Journal of Clinical Microbiology and Infectious Diseases 16, 512-6.
71. Gómez-Lus, M. L., Giménez, M. J., Prieto, J., Martín, M., Frías, J. & Aguilar, L. (1998). Effect of polymorphonuclear neutrophils on serum bactericidal activity against Streptococcus pneumoniae after amoxicillin administration. European Journal of Clinical Microbiology and Infectious Diseases 17, 40-3.
72. Casal, J., Aguilar, L., Jado, I., Yuste, J., Giménez, M. J., Prieto, J. et al. (2002). Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrobial Agents and Chemotherapy 46, 1340-4.
73. Yuste, J., Giménez, M. J., Jado, I., Fenoll, A., Aguilar, L. & Casal, J. (2001). Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-ihibitory concentrations of amoxicillin. Journal of Antimicrobial Chemotherapy 48, 594-5.
74. Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O. et al. (1996). Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. Journal of Infectious Diseases 174, 1271-8.
75. Dagan, R., Givon, N., Yagupsky, P., Porat, N., Janco, J., Chang, I. et al. (1998). Effect of a 9-valent pneumococcal vaccine conjugated to CRM 197 (PncCRM9) on nasopharyngeal carriage of vaccine type and non-vaccine type Streptococcus pneumoniae (Pnc) strains among day care centers attendees. In Program and Abstracts of the Thirty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, USA, 1998. Abstract G-52, p. 299. American Society for Microbiology, Washington, DC, USA.